CNR Institutional Research Information System

PROVENZANO, CLAUDIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 748
NA - Nord America 517
EU - Europa 250
SA - Sud America 130
AF - Africa 12
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.659
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 485
SG - Singapore 282
CN - Cina 152
VN - Vietnam 98
BR - Brasile 96
IT - Italia 85
HK - Hong Kong 63
FR - Francia 48
BD - Bangladesh 37
KR - Corea 32
JP - Giappone 27
DE - Germania 25
NL - Olanda 21
GB - Regno Unito 17
IN - India 16
AR - Argentina 14
MX - Messico 12
AT - Austria 9
ES - Italia 9
CA - Canada 8
FI - Finlandia 8
TR - Turchia 7
ID - Indonesia 6
CO - Colombia 5
EC - Ecuador 5
JM - Giamaica 5
PK - Pakistan 5
PL - Polonia 4
SA - Arabia Saudita 4
SE - Svezia 4
DK - Danimarca 3
IQ - Iraq 3
JO - Giordania 3
MA - Marocco 3
PE - Perù 3
RU - Federazione Russa 3
TN - Tunisia 3
ZA - Sudafrica 3
AL - Albania 2
CL - Cile 2
DO - Repubblica Dominicana 2
EG - Egitto 2
GT - Guatemala 2
HR - Croazia 2
IE - Irlanda 2
IL - Israele 2
KZ - Kazakistan 2
LT - Lituania 2
NP - Nepal 2
PY - Paraguay 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BE - Belgio 1
BO - Bolivia 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
CZ - Repubblica Ceca 1
GP - Guadalupe 1
KE - Kenya 1
KH - Cambogia 1
LB - Libano 1
MY - Malesia 1
NO - Norvegia 1
OM - Oman 1
PT - Portogallo 1
RO - Romania 1
SI - Slovenia 1
SV - El Salvador 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 1.659
Salva come PNG Salva come JPEG
Città #
Singapore 163
Santa Clara 108
Hong Kong 62
San Jose 60
Ashburn 49
Hefei 46
Rome 40
Beijing 39
Dallas 36
Ho Chi Minh City 35
Los Angeles 35
Seoul 32
Lauterbourg 28
Hanoi 24
Frankfurt am Main 17
New York 16
Tokyo 16
Milan 12
Buffalo 9
Orem 8
Rio de Janeiro 7
Ankara 5
Brooklyn 5
Chennai 5
Da Nang 5
Salvador 5
São Paulo 5
Amsterdam 4
Chicago 4
Curitiba 4
London 4
Paris 4
Phoenix 4
Shanghai 4
Stockholm 4
Toronto 4
Atlanta 3
Belo Horizonte 3
Brasília 3
City of London 3
Columbia 3
Ha Long 3
Haarlem 3
Houston 3
Johannesburg 3
Lappeenranta 3
Mexico City 3
Munich 3
Naples 3
Pittsburgh 3
Poplar 3
Thái Bình 3
Turku 3
Vienna 3
Warsaw 3
Aarhus 2
Acalanes Ridge 2
Albuquerque 2
Amman 2
Bengaluru 2
Boardman 2
Bogotá 2
Calvenzano 2
Campinas 2
Can Tho 2
Capitão Poço 2
Clinton 2
Council Bluffs 2
Dublin 2
Elgoibar 2
Guarulhos 2
Guaçuí 2
Helsinki 2
Jakarta 2
Kingston 2
Lahore 2
Lima 2
Marseille 2
Minamishinagawa 2
Montebello 2
Monza 2
Nice 2
Ninh Bình 2
Nuremberg 2
Osaka 2
Palencia 2
Philadelphia 2
Piracicaba 2
Quito 2
Rabat 2
Ribeirão Preto 2
Riyadh 2
Rock Hill 2
San Fernando 2
San Juan 2
São Gonçalo 2
Tewksbury 2
Tokushima 2
Toledo 2
Valencia 2
Totale 1.055
Salva come PNG Salva come JPEG
Nome #
Muscle‐specific gene editing improves molecular and phenotypic defects in a mouse model of myotonic dystrophy type 1 105
BEHAVIOURAL ABNORMALITIES IN DMSXL MICE, A MODEL OF MYOTONIC DYSTROPHY TYPE 1 87
Muscle-specific gene editing improves molecular and phenotypic defects in a mouse model of Myotonic Dystrophy type 1 84
Inducible CRISPR/Cas9 strategy mediates efficient gene editing of trinucleotide repeat expansion in DMPK locus 76
circARHGAP10 as a candidate biomarker and therapeutic target in myotonic dystrophy type 1 74
Study of pathogenetic mechanisms and development of new therapeutic strategies for Myotonic Dystrophy type 1 72
Application of CRISPR/Cas9 strategy for gene therapy of Myotonic Dystrophy type 1 69
High-throughput analysis of the RNAinduced silencing complex in myotonic dystrophy type 1 patients identifies the dysregulation of miR-29c and its target ASB2 68
GENE EDITING IN MYOTONIC DYSTROPHY TYPE 1: ASSESSMENT OF EFFICIENCY, SAFETY AND THERAPEUTIC EFFECT OF CTG-REPEAT DELETION IN A MOUSE MODEL OF DISEASE 66
Gene Therapy Strategies For Myotonic Dystrophy Type 1 65
Circular RNA role in Myotonic Dystrophy type 1 62
Eps8, a tyrosine kinase substrate, is recruited to the cell cortex and dynamic F-actin upon cytoskeleton remodeling. 60
CRISPR/Cas9-mediated genomic deletions of trinucleotide repeats in Myotonic Dystrophy type 1: a new tool for gene therapy? 59
Does the term 'trophic' actually mean anti-amyloidogenic? The case of NGF 58
CRISPR/Cas9-MediatedDeletion ofCTGExpansions Recovers Normal Phenotype in Myogenic Cells Derived from Myotonic Dystrophy 1 Patients 55
Molecular Therapies for Myotonic Dystrophy Type 1: From Small Drugs to Gene Editing 52
Large scale analysis of transcription factor TTF-1/NKX2.1 target genes in GnRH secreting cell line GT1-7 51
Functional characterization of two novel mutations in TTF-1/NKX2.1 homeodomain in patients with benign hereditary chorea 51
GENE EDITING IN MYOTONIC DYSTROPHY TYPE 1: ASSESSMENT OF EFFICIENCY, SAFETY AND THERAPEUTIC EFFECT OF CTG-REPEAT DELETION IN A MOUSE MODEL OF DISEASE 49
Design of novel small molecule base-pair recognizers of toxic CUG RNA transcripts characteristics of DM1 48
Time-controlled and muscle-specific CRISPR/Cas9 mediated deletion of CTG-repeat expansion in the DMPK gene 46
Functional characterization of a novel mutations in TITF-1 in a patient with Benign Hereditary Chorea. 46
MiR-21 is an Ngf-modulated MicroRNA That supports Ngf signaling and regulates neuronal degeneration in PC12 cells 46
Retinoblastoma protein acts as Pax 8 transcriptional coactivator. 37
Regulation of the tyrosine kinase substrate Eps8 expression by growth factors, v-Src and terminal differentiation. 36
Glucocorticoids modulate transformation by v-Src in a cell-specific manner. 34
Transformation of NIH3T3 cells by Rous sarcoma virus occurs with high efficiency in the absence of proviral rearrangements or amplification. 34
Maintenance of the differentiated state in skeletal muscle: activation of v-Src disrupts sarcomeres in quail myotubes 33
MicroRNA-222 regulates muscle alternative splicing through Rbm24 during differentiation of skeletal muscle cells 33
v-Src inhibits myogenic differentiation by interfering with the regulatory network of muscle-specific transcriptional activators at multiple levels 28
A dominant-negative peroxisome proliferator-activated receptor gamma (PPAR gamma) mutant is a constitutive repressor and inhibits PPAR gamma-mediated adipogenesis 27
Totale 1.711
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.366
article - articoli 3.145
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.511
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202436 0 0 0 0 0 0 0 0 0 0 9 27
2024/2025557 8 3 46 19 103 36 17 43 23 24 144 91
2025/20261.083 60 102 115 153 180 53 146 42 41 79 48 64
2026/202735 35 0 0 0 0 0 0 0 0 0 0 0
Totale 1.711